NPC Study Says New Drugs Offset Nondrug Spending: Will CBO Agree?

A National Pharmaceutical Council-funded analysis of the value of newer medicines will give brand name pharmaceutical companies additional evidence to argue that the cost of a Medicare prescription drug benefit may be offset by savings in other health spending.